CD274 and esophageal squamous cell carcinoma: In addition, complications associated with chemoimmunotherapy seem to be less frequent than those associated with concurrent chemoradiotherapy, indicating that PD-L1 inhibitors are safe and efficient for use in ESCC treatment.